Althea Group Holdings Limited (ASX:AGH)
0.0250
0.00 (0.00%)
Jun 27, 2025, 3:56 PM AEST
Althea Group Holdings Company Description
Althea Group Holdings Limited manufactures, distributes, and sells cannabis-based medicines and recreational cannabis products in Australia, the United Kingdom, Canada, Germany, and Ireland.
It also offers education, access, and management services to support eligible patients and healthcare professionals in navigating medicinal cannabis treatment pathways.
In addition, the company provides formulation and manufacturing of recreational cannabis products, such as beverages, edibles, concentrates, and topicals; and owns and operates a private medical cannabis clinic network under the MyAccess Clinics name.
Althea Group Holdings Limited was founded in 2016 and is based in Melbourne, Australia.
Althea Group Holdings Limited

Country | Australia |
Founded | 2016 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
CEO | Joshua Fegan |
Contact Details
Address: Level 19 Melbourne, 3000 Australia | |
Phone | 61 3 0070 2020 |
Website | altheagroupholdings.com |
Stock Details
Ticker Symbol | AGH |
Exchange | Australian Securities Exchange |
Fiscal Year | July - June |
Reporting Currency | AUD |
ISIN Number | AU0000022774 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Joshua Michael Fegan | Chief Executive Officer, MD and Director |
David Sauer | General Counsel |
Adam Gallagher | Company Secretary |